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Abstract
Background: Randomized controlled trials (RCTs) which are of poor quality tend to exaggerate the effect estimate
and lead to wrong or misleading conclusions. The aim of this study is to assess the quality of randomization
methods, allocation concealment and blinding within traditional Chinese medicine (TCM) RCTs, discuss issues
identified for current TCM RCTs, and provide suggestions for quality improvement.
Methods: We searched Chinese Biomedical Database (CBM, 1978 to July 31, 2009) and the Cochrane Library (Issue
2, 2009) to collect TCM systematic reviews and meta-analyses according to inclusion/exclusion criteria, from which
RCTs could be identified. The quality assessment involved whether the randomization methods, allocation
concealment and blinding were adequate or not based the study reported. Stratified analyses were conducted of
different types of diseases published in different journals (both Chinese and foreign) using different interventions.
SPSS 15.0 software was used for statistic analyses.
Results: A total of 3159 RCTs were included, of which 2580 were published in Chinese journals and 579 in foreign
journals. There were 381 (12%) RCTs which used adequate randomization methods; 207 (7%) RCTs which used
adequate allocation concealment and 601 (19%) which used adequate blinding; there were 130 (4%) RCTs which
both used adequate randomization methods and allocation concealment; and there were only 100 (3%) RCTs
which used adequate randomization methods, allocation concealment, as well as blinding. In the RCTs published
in foreign journals, the adequate randomization methods, allocation concealment and blinding accounted for a
relatively large proportion (25%, 26%, and 60%, respectively) and increased with years, while in the RCTs published
in Chinese journals, only the adequate randomization methods improved over time. The quality of non-drug
intervention (chiefly acupuncture) RCTs was higher than that of drug intervention RCTs. In drug intervention, the
quality of listed drugs is higher than the others. The quality of all included RCTs of all types of diseases was
generally poor and no studies that were large in size and of high quality were found.
Conclusion: The quality of the current TCM RCTs as judged by their publications is generally poor, especially those
published in Chinese journals. In future, researchers of TCM RCTs should attach more importance to experimental
design and methodological quality, receive relevant training, and improve reporting quality using the Consolidated
Standards of Reporting Trials (CONSORT) statement, so as to improve the quality of TCM clinical research and
ensure truth and reliability of conclusions.
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Traditional Chinese medicine (TCM) is centuries old
and has developed a unique system of diagnosis and
treatment of disease in the practice [1]. TCM is not
only an important part of Chinese health but also is
accepted in many parts of the world thus offering a
complementary or alternative form of health care. Inter-
national medicine has been increasingly interested in
TCM [2-4]. Randomized controlled trials (RCTs) and
systematic reviews are commonly regarded first-class
evidence in judging the treatment effect of interventions
[5,6]. Systematic reviews are based on RCTs, whose defi-
ciency may yield unreliability of the conclusions [7,8],
therefore, the quality of included RCTs is of obvious
relevance to the interpretability and reliability of the
conclusions. Research shows that the RCTs which are of
poor quality tend to exaggerate the effect estimates and
lead to misleading conclusions [9-16]. The aim of this
study is to assess the quality of randomization methods,
allocation concealment and blinding of TCM RCTs
based on study reports, discuss issues identified for cur-
rent TCM RCTs, and provide suggestions for quality
improvement.
Methods
Literature selection
The following databases were searched: Chinese Biome-
dical Database (CBM, 1978 to July 31, 2009) and the
Cochrane Library 2009, Issue 2.
The following search strategies were used:
CBM:
#1 title: systematic review (in Chinese)
#2 keywords: systematic review (in Chinese)
#3 title: systematic overview (in Chinese)
#4 keywords: systematic overview (in Chinese)
#5 title: meta analysis (in Chinese)
#6 keywords: meta analysis (in hinese)
#7 title: meta-analysis (in Chinese)
#8 keywords: meta-analysis (in Chinese)
#9 title: systematic review (in English)
#10 keywords: systematic review (in English)
#11 title: systematic reviews (in English)
#12 keywords: systematic reviews (in English)
#13 title: meta analysis (in English)
#14keywords: meta analysis (in English)
#15 title: meta-analysis (in English)
#16 keywords: meta-analysis (in English)
#17 title: meta analyses (in English)
#18 keywords: meta analyses (in English)
#19 title: meta-analyses (in English)
#20 keywords: meta-analyses (in English)
#21 #1-20/or
The Cochrane Library 2009, Issue 2
#1 herb in Title, Abstract or Keywords
#2 herbal in Title, Abstract or Keywords
#3 herbs in Title, Abstract or Keywords
#4 Chinese in Title, Abstract or Keywords
#5 China in Title, Abstract or Keywords
#6 acupuncture in Title, Abstract or Keywords
#7 alternative complementary medicine in Title,
Abstract or Keywords
#8 plant in Title, Abstract or Keywords
#9 moxibustion in Title, Abstract or Keywords
#10 #1~#9/or
All identified RCTs, published in Chinese journals and
The Cochrane Library, included in systematic reviews
and meta-analyses of TCM (including Chinese herbal
medicine, Chinese medicine, Chinese standardized
remedies, Chinese medicine preparations and Chinese
medicine extracts), integrated TCM and Biomedicine, as
well as acupuncture and massage (including acupunc-
ture and electro-acupuncture), were included. Repeat-
edly-published articles, translated articles, non-full text
articles and articles without mentioning sources of
RCTs were excluded.
Quality assessment
The quality assessment in this study was performed
according to three major procedures in methodological
part of the Cochrane Handbook: ① Whether the rando-
mization method was adequate (such as referring to a ran-
domized number table, using a computer random number
generator, coin tossing and throwing dice, etc.) or inade-
quate (such as sequence generated by odd or even date of
birth, sequence generated by some rule based on date of
admission or hospital record number, etc.). ② Whether
allocation concealment was adequate (such as central allo-
cation, sequentially numbered drug containers of identical
appearance, sequentially numbered, opaque, sealed envel-
opes, etc) or inadequate (such as using an open random
allocation schedule, alternation or rotation, date of birth,
case record number, etc.). ③ Whether blinding was ade-
quate (such as no blinding, but the review authors judge
that the outcome and the outcome measurement are not
likely to be influenced by lack of blinding; blinding of par-
ticipants and key study personnel ensured, and unlikely
that the blinding could have been broken; either partici-
pants or some key study personnel were not blinded, but
outcome assessment was blinded and the non-blinding of
others unlikely to introduce bias) or inadequate (such as
no blinding or incomplete blinding, and the outcome or
outcome measurement is likely to be influenced by lack of
blinding; blinding of key study participants and personnel
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broken, either participants or some key study personnel
were not blinded, and the non-blinding of others likely to
introduce bias) [17]. Assessment was based on trial publi-
cation only. We did not contact trial authors for
clarification.
Stratified analysis
Included RCTs were published in Chinese journals or
foreign journals.
Medicine and non-medicine interventions were
divided with the former including listed medicines (Chi-
nese standardized remedies, Chinese medicine extracts
and single herbs), individualized prescription, mixture
(listed medicines and individualized prescription) and
unclear (the intervention was not reported).
Types of Diseases: classified according to the 10
th ver-
sion of the international disease classification (ICD-10)
[18].
Data extraction
The researchers used EndNote software to manage titles
and abstracts of citations obtained through database
search. They(J He, and L Du) read titles and abstracts
for primary screening based on the inclusion criteria,
and then acquired the full text to read for further
screening, before finally deciding whether they would be
included or not. Four researchers extracted data, using a
pro-forma, and then input the extracted materials into
Epidata software. Two other researchers checked the
data. Any differences were settled through discussion.
Data analysis
SPSS 15.0 was used for descriptive analyses and c
2 test.
Results
A total of 2041 articles were retrieved (1790 from CBM
and 251 from The Cochrane Library). After the primary
screening, there were 1781 articles were excluded and
260 articles (173 from CBM and 87 from The Cochrane
Library) were included. A total of 3159 RCTs were iden-
tified from the 260 systematic reviews/meta-analyses, of
which 2580 were published in Chinese journals and 579
in foreign journals (Figure 1).
Assessment of reported randomization methods,
allocation concealment and blinding
A total of 3159 RCTs were included, among which 381
(12%) used adequate randomization methods; 207 (7%)
used adequate allocation concealment; 601 (19%) used
adequate blinding; 130 (4%) both used adequate rando-
mization methods and allocation concealment; 100 (3%)
were adequate for all three methods.
RCTs published in foreign journals were better than
those published in Chinese journals, and the difference
was significant (P = 0.000) (Table 1).
Changes of RCTs reported quality with time
All 3159 RCTs were published between 1965 and 2008
(Figure 2). The proportion of adequate randomization
methods of RCTs increased year by year, but there was
no clear increase in allocation concealment and blind-
ing, and the allocation concealment accounted for a
very small proportion (Figure 3). In terms of Chinese
journals, the proportion of adequate randomization
methods of RCTs between 1993 and 2007 increased
sharply, but there was no clear increase in the allocation
concealment and blinding, and the allocation conceal-
ment just occupied a very small proportion (Figure 4).
By comparison, there was a large rise in the proportion
of adequate randomization methods, allocation conceal-
ment and blinding of the RCTs published in foreign
journals from 1993 through 2007 (Figure 5). In order to
avoid bias caused by chance, RCTs published between
1965 and 1992, as well as in 2008, which number of the
included RCTs was very small, were excluded from this
analysis.
Reported quality of RCTs of different interventions
Among 3159 included RCTs, 2546 (81%) were drug
interventions and 613 (19%) were non-drug interven-
tions. In the non-drug group, the proportion of ade-
quate randomization methods, allocation concealment
and blinding were 21%, 19%, and 38%, respectively,
which were larger than those in drug intervention, and
the difference were significant (P = 0.000) (Table 2).
2041 systematic reviews 
(1790 from CBM and 251 from Cochrane Library) 
1700 non-TCM systematic reviews 
(1545 from CBM and 155 from Cochrane Library) 
341 TCM systematic reviews 
(245 from CBM and 96 from Cochrane Library) 
80 systematic reviews lacked original RCTs
(71 from CBM and 9 from Cochrane Library) 
261 TCM systematic reviews 
(174 from CBM and 87 from Cochrane Library) 
1 systematic reviews lacked full text 
(1 from CBM and 0 from Cochrane Library) 
260 TCM systematic reviews 
(173 from CBM and 87 from Cochrane Library) 
3159 TCM RCTs 
(2580 in Chinese journals and 579 in foreign journals)
Figure 1 Flow chart of literature selection.
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randomization of Chinese standardized remedies RCTs
were the largest (13%), the proportion of adequate alloca-
tion concealment of Chinese medicine extracts RCTs were
the largest (9%), and the proportion of adequate blinding
of single herbs RCTs were the largest (40%).
In different non-drug intervention, the proportion of
adequate randomization and blinding (22% and 41%,
respectively) of acupuncture RCTs were larger, and the
proportion of adequate allocation concealment (19%) of
acupuncture RCTs was the same with massage RCTs.
In terms of drug intervention RCTs published in foreign
journals, except that the proportion of adequate randomi-
zation methods of mixed RCTs (including listed medicine
and individualized prescription) and unclear RCTs were
smaller than those of RCTs published in Chinese journals,
other proportion of adequate randomization methods,
allocation concealment, and blinding were all larger than
those of RCTs published in Chinese journals.
In terms of non-drug RCTs published in foreign jour-
nals, the proportion of adequate randomization meth-
ods, allocation concealment and blinding were all larger
than those of RCTs published in Chinese journals.
Reported quality of RCTs of different types of diseases
The included 3159 RCTs were classified according
to the 10th version of the international disease
classification (ICD-10), involving 16 types of diseases
and lacking 5 types (Table 3). Quantities and qualities
of all types of diseases had imbalanced distribution.
Circulatory system RCTs had the largest number but
were of low quality.
Discussion
Many studies have showed that RCTs not using rando-
mization, allocation concealment or blinding exaggerate
estimates of effect to various extents. Compared with
the RCTs using blinding, the RCTs not using blinding
yield 17% larger estimates of treatment effects and in
trials with subjective outcomes, effect estimates are
exaggerated by 25%. Compared with the RCTs using
adequate allocation concealment, RCTs using unclear or
inadequate concealment of allocation exaggerate esti-
mates of effect by 30%-41% [10-14]. These showed that
compared with other “flaws”, unclear or inadequate allo-
cation concealment will cause a larger bias, which high-
lights the importance of allocation concealment. This
study indicates that the adequate allocation concealment
takes up the smallest proportion (7%) of the three
assessed aspects. Although the adequate randomization
methods accounted for a larger proportion (12%) than
allocation concealment, there are also some investiga-
tions which showed that only 6.8% of the RCTs pub-
lished in Chinese journals were deemed authentic
randomized trials [19]. So the quality of the TCM RCTs
in this study may be overstated.
Compared with those published in Chinese journals,
the TCM RCTs published in foreign journals are of
higher quality. In terms of changes over time, the pro-
portion of reports of adequate randomization has
increased year on year, suggesting that more attention
has been paid to the randomization methods of Chinese
TCM RCTs. However, the proportion of adequate allo-
cation concealment and blinding are small and has
remained at approximately the same level. By contrast,
the proportion of adequate randomization methods,
allocation concealment and blinding of the TCM RCTs
published in foreign journals has increased overtime.
Table 1 Characters of randomization methods, allocation concealment and blinding of included RCTs
Item Chinese Foreign Total c2* P
Adequate Inadequate n Adequate Inadequate n Adequate Inadequate N
(%) (%) (%) (%) (%) (%)
randomization methods 239(9) 2341(91) 2580 142(25) 437(75) 579 381(12) 2778(88) 3159 103.8 0.000
allocation concealment 56(2) 2524(98) 2580 151(26) 428(74) 579 207(7) 2952(93) 3159 441.4 0.000
blinding 252(10) 2328(90) 2580 349(60) 230(40) 579 601(19) 2558(81) 3159 783.1 0.000
randomization method + allocation
concealment
39(2) 2541(98) 2580 91(16) 488(84) 579 130(4) 3029(96) 3159 241.8 0.000
randomization method + allocation
concealment + blinding
33(1) 2547(99) 2580 67(12) 512(88) 579 100(3) 3059(97) 3159 163.4 0.000
* Proportion of adequate comparison of Chinese with foreign.
Figure 2 Numbers of 3159 RCTs with years.
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Figure 3 Reported quality of RCTs between 1993 and 2007 (n=2909) 
Figure 3 Reported quality of RCTs between 1993 and 2007 (n = 2909).
Figure 4 Reported quality of RCTs published in Chinese journals between 1993 and 2007 (n=2535) 
 
Figure 4 Reported quality of RCTs published in Chinese journals between 1993 and 2007 (n = 2535).
Figure 5 Reported quality of RCTs published in foreign journals between 1993 and 2007 (n = 374).
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Number of RCTs Adequate randomization
methods
Adequate allocation
concealment
Adequate blinding
Classification Chinese Foreign Total Chinese Foreign Total Chinese Foreign Total Chinese Foreign Total
(%) (%) (%) (%) (%) (%) (%) (%) (%)
Drug Chinese standardized remedies 1135 42 1177 140(12) 13(31) 153(13) 32(3) 13(31) 45(4) 148(13) 36(86) 184(16)
Chinese medicine extracts 241 107 348 7(3) 26(24) 33(9) 3(1) 30(28) 33(9) 12(5) 37(35) 49(14)
Single herb 100 67 167 3(3) 9(13) 12(7) 0(0) 5(7) 5(3) 5(5) 62(93) 67(40)
Individualized prescription 562 13 575 41(7) 4(31) 45(8) 1(0) 4(31) 5(1) 24(4) 10(77) 34(6)
Mixture 115 20 135 4(3) 0(0) 4(3) 0(0) 0(0) 0(0) 10(9) 19(95) 29(21)
Unclear 141 3 144 4(3) 0(0) 4(3) 3(2) 1(33) 4(3) 3(2) 0(0) 3(2)
Total 2294 252 2546 199(9) 52(21) 251(10) 39(2) 53(21) 92(4) 202(9) 164(65) 366(14)
Non-drug Acupuncture 263 219 482 37(14) 69(32) 106(22) 17(6) 73(33) 90(19) 49(19) 149(68) 198(41)
Massage 23 108 131 3(13) 21(19) 24(18) 0(0) 25(23) 25(19) 1(4) 36(33) 37(28)
Total 286 327 613 40(14) 90(28) 130(21) 17(6) 98(30) 115(19) 50(17) 185(57) 235(38)
c2 59.99 185.10 184.11
P 0.000 0.000 0.000
* Comparison of drugs with non-drugs
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9Table 3 Characters of RCTs of different types of diseases (Chinese journals VS foreign journals)
Types of diseases Number of RCTs Adequate randomization methods Adequate allocation concealment Adequate blinding
Chinese Foreign Total Chinese Foreign Total Chinese Foreign Total Chinese Foreign Total
(%) (%) (%) (%) (%) (%) (%) (%) (%)
Certain infectious and parasitic diseases 197 71 268 7(4) 19(27) 26(10) 6(3) 14(20) 20(7) 13(7) 20(28) 33(12)
Neoplasm 120 33 153 5(4) 1(3) 6(4) 0(0) 14(42) 14(9) 6(5) 12(36) 18(12)
Diseases of the blood and blood-forming
organs and certain disorders involving the
immune mechanism
32 9 41 1(3) 5(56) 6(15) 1(3) 3(33) 4(10) 2(6) 7(78) 9(22)
Endocrine, nutritional and metabolic
diseases
200 6 206 32(16) 0(0) 32(16) 6(3) 0(0) 6(3) 26(13) 4(67) 30(15)
Mental and behavioural disorders 97 96 193 21(22) 12(13) 33(17) 14(14) 8(8) 22(11) 29(30) 85(89) 114(59)
Diseases of the nervous system 56 39 95 4(7) 19(49) 23(24) 0(0) 19(49) 19(20) 2(4) 27(69) 29(31)
Diseases of the eye and adnexa 17 3 20 6(35) 1(33) 7(35) 0(0) 2(67) 2(10) 9(53) 2(67) 11(55)
Diseases of the ear and mastoid process 4 0 4 1(25) 0(0) 1(25) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0)
Diseases of the circulatory system 978 19 997 81(8) 9(47) 90(9) 11(1) 8(42) 19(2) 79(8) 13(68) 92(9)
Diseases of the respiratory system 150 39 189 34(23) 6(15) 40(21) 11(7) 8(21) 19(10) 28(19) 27(69) 55(29)
Diseases of the digestive system 270 14 284 9(3) 5(36) 14(5) 0(0) 8(57) 8(3) 1(0) 7(50) 8(3)
Diseases of the skin and subcutaneous
tissue
49 6 55 10(20) 2(33) 12(22) 0(0) 2(33) 2(4) 10(20) 4(67) 14(25)
Diseases of the musculoskeletal system and
connective tissue
141 168 309 11(8) 35(21) 46(15) 4(3) 31(18) 35(11) 29(21) 90(54) 119(39)
Diseases of the genitourinary system 220 18 238 11(5) 5(28) 16(7) 3(1) 6(33) 9(4) 16(7) 10(56) 26(11)
Pregnancy, childbirth and the puerperium 42 47 89 6(14) 23(49) 29(33) 0(0) 28(60) 28(31) 2(5) 39(83) 41(46)
Symptoms, signs and abnormal clinical and
laboratoty findings, not elsewhere calssified
2 9 11 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 1(11) 1(9)
Factors influencing health status and
contact with health services
5 2 7 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 1(50) 1(0)
Total 2580 579 3159 239(9) 142(25) 381(12) 56(2) 151(26) 207(7) 252(10) 349(60) 601(19)
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9This suggests that Chinese journals are failing to
improve the standards of published RCTs.
Acupuncture, thousands of years of history in China, is
a traditional medicine recognized by the World Health
Organisation and has become a component of health
care in many countries [20]. Since late 1990s, numbers of
acupuncture clinical trials have grown dramatically with
the increase of research funds in western countries [21].
The results of this study shows that in the light of inter-
ventions of TCM RCTs, the quality of non-drug interven-
tion is evidently higher than that of drug intervention,
and acupuncture is the largest group. In drug interven-
tion, the quality of RCTs of Chinese standardized reme-
dies, Chinese medicine extracts and single herbs is
comparatively high while that of individualized prescrip-
tion, mixtures (including listed medicine and individua-
lized prescription) and those where the intervention is
unclear is low. Individualized prescription which is com-
m o ni nT C Mi si n f l u e n c e db yad o c t o r ’se x p e r i e n c ea n d
training. There are no agreed formulae for drug ingredi-
ents, no standard sources of drugs, or preparation meth-
ods. In addition, doses of Chinese herbs are not standard.
Listed medicine and single herbs can overcome the above
shortcomings of individualized prescription, so the qual-
ity of RCTs of these kinds is higher and clinical research
develops in a more extensive way.
With the development of TCM, current TCM RCTs
involve wide study fields and many types of diseases.
This study was aimed at determining which medical
specialties produce with high-quality RCTs, but these
were not identified.
The quality assessment in this study was based on how
the original study was reported, so it was affected by the
quality of reporting. There also may be some other fac-
tors not in the power of the reseachers such as journal
word length etc. Some studies have showed that use of
the Consolidated Standards of Reporting Trials (CON-
SORT) statement is associated with improvements in the
reporting quality of RCTs, but few researchers and jour-
nals adopt it [22-30]. The CONSORT extensions for acu-
puncture (the Standards for Reporting Interventions in
Clinical Trials of Acupuncuture, STRICTA) and herbal
medicine were designed to improve the completeness
and transparency of reporting of interventions in con-
trolled trials of acupunture and herbal medicine [31,32].
Conclusion
The quality of the current TCM RCTs as judged by their
publications is generally poor, especially those published
in Chinese journals. In future, researchers should attach
more importance to design and methodological quality,
especially to allocation concealment. The quality of RCTs
can also be improved through promoting participation of
methodologists and statisticians, enhancing international
cooperation, and adopting guidelines such as the CON-
SORT statement and its extensions for acupuncture and
herbal medicine. Meanwhile, medical journals should
also be more discerning in what they accept for publica-
tion, so as to improve the quality of TCM clinical
research and ensure truth and reliability of conclusions.
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